

Tumors of the digestive tract About theme
The mission of this research theme is to arrive at an optimal classification of patients to improve surveillance, diagnosis, treatment, and outcome for patients with cancer of the digestive tract. read moreTumors of the digestive tract About theme
Our mission is to arrive at an optimal classification of patients to improve surveillance, diagnosis, treatment, and outcome for patients with cancer of the digestive tract.In our theme, we are committed to improving outcome for patients with cancer of the digestive tract. To this end, we aim our research at selecting patients for their personalized trajectory. We use basic, translational, and clinical research to provide the evidence for this trajectory. This involves surveillance and early detection, optimal diagnosis including molecular analyses and innovative imaging, and innovation in treatment, ranging from improved surgical techniques to immunotherapy.
Objectives
- We will identify new genes responsible for hereditary colorectal cancer syndromes.
- We will develop strategies for improving detection of hereditary forms of pancreatic cancer.
- We aim to prevent cancer in high-risk patients using vaccination and lifestyle interventions.
- We will develop new molecular diagnostic tools to predict tumor response to therapy.
- We will identify relevant biomarkers for the development of metastatic disease and implement these factors in daily practice.
- We will develop surgical techniques to optimize patient care.
Lines of research
Discovery of novel genetic and exposure factors
This includes both fundamental research, focusing on intestinal microbiota that drive hereditary cancer, as well as improvement of identification and stratification of patients who develop cancer as a result of these cancer syndromes. read moreDiscovery of novel genetic and exposure factors
This includes both fundamental research, focusing on intestinal microbiota that drive hereditary cancer, as well as improvement of identification and stratification of patients who develop cancer as a result of these cancer syndromes, as has been successfully achieved for Lynch syndrome patients.Evidence-based pathology
Detection, validation, and implementation of new and classic biomarkers in the different patient cohorts have direct effect on treatment of patients. read moreEvidence-based pathology
Detection, validation, and implementation of new and classic biomarkers in the different patient cohorts have direct effect on treatment of patients. This topic together with the previous research line come together in the Laboratory for tumor genetics, where patient care is combined with biomarker research.Innovative treatment modalities
Such as organ sparing approaches, novel surgical interventions and local techniques using novel imaging tools. read moreInnovative treatment modalities
Innovative treatment modalities, such as organ sparing approaches, novel surgical interventions and local techniques using novel imaging tools.News, events, impact and organization
-
Milou van Riswijk wins a research grant at the Champions’ Denat the ESGE days 202223 May 2022
-
What can we learn from rural Tanzanian food?23 December 2021
-
Pathology reporting of gastric endoscopic resections:Recommendations from the International Collaboration on Cancer Reporting17 November 2021
Answers in Dutch
Information on our research can also be found in Dutch on the Nationale Wetenschapsagenda website. The information here answers questions asked by Dutch citizens.
visit websiteSocietal impact
- Lynch syndrome from basic research to implementation in daily clinical practice
- Microbiome: from association studies towards clinically relevant tools
- Evidence-based pathology: guiding personalized treatment
- Imaging: getting ready for the next challenges
- Surgery: improved outcomes due to improved care
- Epidemiology: Study of variation to improve future care